Today is World Vegan Day, an annual event celebrated on November 1st. World Vegan Day is an opportunity to promote the benefits of a vegan diet (a vegan diet involves eating only plant-based foods) and veganism in general. People observing the day celebrate the benefits of veganism for humans, animals and the environment. The day also kicks off World Vegan Month.
Health Highlight: Researchers use gut bacteria to map genetic mutations in colorectal cancer tumours
Colorectal cancer is now understood to be definitely linked to microbial problems in the gut. Research has shown that the disease is linked with less numbers and diversity in the gut microbiome, and with the increased presence of more harmful strains. Therefore using gut bacteria to diagnose and even aid in cancer prevention is highly desirable due to it’s quick, non-invasive ease of investigation.
Now, a study from researchers at University of Minnesota has predicted key genetic mutations in colorectal tumours by analyzing the types of gut bacteria present around them. The team state that it could be possible to genetically classify the colorectal tumour a person has without having to do a biopsy and dissect it. Their findings were presented at the American Society of Human Genetics (ASHG) 2015 Annual Meeting.
Source: Healthinnovations
Health Highlights is a recurring series of curated health and medical news from around the web.
Men’s Health Week: Get It Checked
Men face unique health challenges, and one of the most dangerous is their reluctance to seek healthcare. Each year in the week leading up to Father’s Day, Men’s Health Week shines a spotlight on many of the issues that affect the male population. This year, Men’s Health Week runs between June 10th–16th. It is observed as part of the larger Men’s Health Month, which is celebrated during the month of June with screenings, health fairs, media appearances, and other health education and outreach activities.
2012: Banner Year for New Drugs
Fueled by new cancer therapeutics, last year the annual new molecular and biological entity approval count from the U.S. Food and Drug Administration (FDA) saw its highest year since 1997. One-third of the novel products approved by the FDA’s Center for Drug Evaluation and Research (CDER) are used to treat cancers of the blood, breast, colon, prostate, skin and thyroid.